Virtu Financial LLC Synthetic Biologics, Inc. Transaction History

Virtu Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.9 - $2.9 $582,310 - $888,789	-306,479 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$2.3 - $4.3 $57,647 - $107,775	-25,064 Reduced 7.56%	306,479 $87,000
Q4 2021 Feb 17, 2022	BUY	$2.7 - $4.5 $375,834 - $626,391	139,198 Added 72.37%	331,543 $90,000
Q3 2021 Nov 12, 2021	SELL	$4.3 - $5.8 $247,477 - $333,807	-57,553 Reduced 23.03%	192,345 $88,000
Q2 2021 Sep 17, 2021	SELL	$4.6 - $7.2 $997,307 - $1.56 Million	-216,806 Reduced 46.45%	249,898 $151,000
Q1 2021 May 19, 2021	BUY	$5.0 - $11.7 $1.81 Million - $4.24 Million	362,319 Added 347.1%	466,704 $318,000
Q4 2020 Feb 24, 2021	BUY	$2.9 - $4.6 $302,716 - $480,170	104,385 New	104,385 $40,000
Q2 2019 Aug 13, 2019	SELL	$4.9 - $6.6 $460,943 - $620,862	-94,070 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$5.9 - $8.1 $482,926 - $663,001	81,852 Added 669.93%	94,070 $64,000
Q4 2018 Jan 16, 2019	SELL	$5.2 - $26.8 $111,898 - $576,709	-21,519 Reduced 63.78%	12,218 $7,000
Q3 2018 Nov 13, 2018	BUY	$20.4 - $80.5 $688,234 - $2.72 Million	33,737 New	33,737 $88,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.